Ramsay Générale de Santé SA
Ramsay Générale de Santé SA (GDS.PA) Stock Competitors & Peer Comparison
See (GDS.PA) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
---|---|---|---|---|---|---|
GDS.PA | €10.50 | -0.47% | 1.2B | -14.58 | -€0.72 | N/A |
CLARI.PA | €4.56 | +3.64% | 1.6B | -113.90 | -€0.04 | N/A |
ORP.PA | €8.39 | +3.94% | 1.3B | 0.06 | €129.13 | N/A |
KORI.PA | €7.36 | -3.79% | 778.6M | 29.44 | €0.25 | N/A |
LNA.PA | €28.50 | +2.89% | 291.4M | 13.38 | €2.13 | +4.56% |
PNSB.BR | €0.40 | N/A | 245K | N/A | N/A | N/A |
MLSBT.PA | €5.30 | -2.75% | 0 | -17.10 | -€0.31 | N/A |
ESP.AS | €0.01 | +0.00% | 0 | -0.01 | -€0.92 | N/A |
Stock Comparison
GDS.PA vs CLARI.PA Comparison August 2025
GDS.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDS.PA stands at 1.2B. In comparison, CLARI.PA has a market cap of 1.6B. Regarding current trading prices, GDS.PA is priced at €10.50, while CLARI.PA trades at €4.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDS.PA currently has a P/E ratio of -14.58, whereas CLARI.PA's P/E ratio is -113.90. In terms of profitability, GDS.PA's ROE is -0.07%, compared to CLARI.PA's ROE of -0.00%. Regarding short-term risk, GDS.PA is less volatile compared to CLARI.PA. This indicates potentially lower risk in terms of short-term price fluctuations for GDS.PA.Check CLARI.PA's competition here